Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100136

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100136

Europe Whole Exome Sequencing Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Europe whole exome sequencing (WES) market is projected to register a substantial CAGR of 16.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.

Market Segmentation:

Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.

Europe whole exome sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.

On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.

On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.

On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.

On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.

On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.

Some of the major factors contributing to the growth of the Europe Whole Exome Sequencing (WES) market are:

Strategic Initiatives by the key market player

Adoption of WES technology by new consumers

Market Players:

The key market players for Europe whole exome sequencing (WES) market are listed below:

BIONEER CORPORATION

ExoDx (a part of Bio-Techne)

FOUNDATION MEDICINE, INC. (A subsidiary of F. Hoffmann-La Roche Ltd)

GeneFirst Limited

CeGaT GmbH

TABLE OF CONTENTS

1 INTRODUCTION 33

  • 1.1 OBJECTIVES OF THE STUDY 33
  • 1.2 MARKET DEFINITION 33
  • 1.3 OVERVIEW OF EUROPE WHOLE EXOME SEQUENCING (WES) MARKET 33
  • 1.4 CURRENCY AND PRICING 35
  • 1.5 LIMITATIONS 35
  • 1.6 MARKETS COVERED 36

2 MARKET SEGMENTATION 39

  • 2.1 MARKETS COVERED 39
  • 2.2 GEOGRAPHICAL SCOPE 40
  • 2.3 YEARS CONSIDERED FOR THE STUDY 41
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 42
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
  • 2.6 MULTIVARIATE MODELLING 46
  • 2.7 MARKET APPLICATION COVERAGE GRID 47
  • 2.8 PRODUCT TYPE LIFELINE CURVE 48
  • 2.9 DBMR MARKET POSITION GRID 49
  • 2.10 VENDOR SHARE ANALYSIS 51
  • 2.11 SECONDARY SOURCES 52
  • 2.12 ASSUMPTIONS 52

3 EXECUTIVE SUMMARY 53

4 PREMIUM INSIGHT 57

  • 4.1 PORTER'S FIVE FORCES 58
  • 4.2 PESTEL ANALYSIS 59
  • 4.3 INDUSTRIAL INSIGHTS: 60
  • 4.4 CONCLUSION 61

5 EUROPE WHOLE EXOME SEQUENCING MARKET: REGULATIONS 62

6 MARKET OVERVIEW 64

  • 6.1 DRIVERS 66
    • 6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS 66
    • 6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING 66
    • 6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING 66
    • 6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION 67

  • 6.2 RESTRAINTS 68
    • 6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS 68
    • 6.2.2 CYBER SECURITY CONCERNS IN GENOMICS 68
  • 6.3 OPPORTUNITIES 69
    • 6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 69
    • 6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS 69
  • 6.4 CHALLENGES 70
    • 6.4.1 LACK OF SKILLED PROFESSIONALS 70
    • 6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING 70

7 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT 71

  • 7.1 OVERVIEW 72
  • 7.2 SECOND-GENERATION SEQUENCING 75
    • 7.2.1 SEQUENCING BY SYNTHESIS (SBS) 76
    • 7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL) 76
  • 7.3 THIRD-GENERATION SEQUENCING 77

8 EUROPE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE 78

  • 8.1 OVERVIEW 79
  • 8.2 SYSTEMS 82
    • 8.2.1 HISEQ SERIES 83
      • 8.2.1.1 HISEQ 2500 83
      • 8.2.1.2 HISEQ 1500 83
    • 8.2.2 MISEQ SERIES 83
    • 8.2.3 ION TORRENT PLATFORMS 84
      • 8.2.3.1 ION PROTON 84
      • 8.2.3.2 ION PGM 84
    • 8.2.4 OTHERS 84
  • 8.3 KITS 84
    • 8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 85
    • 8.3.2 LIBRARY PREPARATION KITS 85
    • 8.3.3 TARGET ENRICHMENT KITS 86
    • 8.3.4 OTHERS 86
  • 8.4 SERVICES 86
    • 8.4.1 SEQUENCING SERVICES 87
    • 8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES 87
    • 8.4.3 OTHERS 87

9 EUROPE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 88

  • 9.1 OVERVIEW 89
  • 9.2 DRUG DISCOVERY AND DEVELOPMENT 92
  • 9.3 AGRICULTURE & ANIMAL RESEARCH 93
  • 9.4 DIAGNOSTICS 93
  • 9.5 PERSONALIZED MEDICINE 94
  • 9.6 OTHERS 95

10 EUROPE WHOLE EXOME SEQUENCING MARKET, BY END USER 96

  • 10.1 OVERVIEW 97
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
  • 10.3 ACADEMIC & RESEARCH INSTITUTES 101
  • 10.4 HOSPITALS AND CLINICS 101
  • 10.5 CLINICAL LABORATORIES 102
  • 10.6 OTHERS 103

11 EUROPE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL 104

  • 11.1 OVERVIEW 105
  • 11.2 DIRECT TRADE 108
  • 11.3 RETAIL SALES 108
  • 11.4 OTHERS 110

12 EUROPE WHOLE EXOME SEQUENCING MARKET, BY REGION 111

  • 12.1 EUROPE 112
    • 12.1.1 GERMANY 120
    • 12.1.2 FRANCE 124
    • 12.1.3 U.K. 127
    • 12.1.4 RUSSIA 131
    • 12.1.5 ITALY 134
    • 12.1.6 SPAIN 137
    • 12.1.7 TURKEY 140
    • 12.1.8 NETHERLANDS 143
    • 12.1.9 SWITZERLAND 147
    • 12.1.10 BELGIUM 151
    • 12.1.11 REST OF EUROPE 155

13 EUROPE WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE 156

  • 13.1 COMPANY SHARE ANALYSIS: EUROPE 156

14 COMPANY PROFILE 157

  • 14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.) 157
    • 14.1.1 COMPANY SNAPSHOT 157
    • 14.1.2 REVENUE ANALYSIS 157
    • 14.1.3 COM PANY SHARE ANALYSIS 158
    • 14.1.4 PRODUCT PORTFOLIO 158
    • 14.1.5 RECENT DEVELOPMENTS 158
  • 14.2 MERCK KGAA 160
    • 14.2.1 COMPANY SNAPSHOT 160
    • 14.2.2 REVENUE ANALYSIS 160
    • 14.2.3 COM PANY SHARE ANALYSIS 161
    • 14.2.4 PRODUCT PORTFOLIO 161
    • 14.2.5 RECENT DEVELOPMENTS 161
  • 14.3 EXODX (A PART OF BIO-TECHNE) 162
    • 14.3.1 COMPANY SNAPSHOT 162
    • 14.3.2 REVENUE ANALYSIS 162
    • 14.3.3 COM PANY SHARE ANALYSIS 163
    • 14.3.4 PRODUCT PORTFOLIO 163
    • 14.3.5 RECENT DEVELOPMENTS 163
  • 14.4 THERMO FISHER SCIENTIFIC INC. 164
    • 14.4.1 COMPANY SNAPSHOT 164
    • 14.4.2 REVENUE ANALYSIS 164
    • 14.4.3 COM PANY SHARE ANALYSIS 165
    • 14.4.4 PRODUCT PORTFOLIO 165
    • 14.4.5 RECENT DEVELOPMENTS 165
  • 14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 166
    • 14.5.1 COMPANY SNAPSHOT 166
    • 14.5.2 REVENUE ANALYSIS 166
    • 14.5.3 COM PANY SHARE ANALYSIS 167
    • 14.5.4 PRODUCT PORTFOLIO 167
    • 14.5.5 RECENT DEVELOPMENTS 167
  • 14.6 AZENTA US, INC. 169
    • 14.6.1 COMPANY SNAPSHOT 169
    • 14.6.2 PRODUCT PORTFOLIO 169
    • 14.6.3 RECENT DEVELOPMENTS 169
  • 14.7 BECKMAN COULTER, INC 171
    • 14.7.1 COMPANY SNAPSHOT 171
    • 14.7.2 REVENUE ANALYSIS 171
    • 14.7.3 PRODUCT PORTFOLIO 172
    • 14.7.4 RECENT DEVELOPMENTS 172
  • 14.8 BIONEER CORPORATION 173
    • 14.8.1 COMPANY SNAPSHOT 173
    • 14.8.2 REVENUE ANALYSIS 173
    • 14.8.3 PRODUCT PORTFOLIO 174
    • 14.8.4 RECENT DEVELOPMENTS 174
  • 14.9 CD GENOMICS 175
    • 14.9.1 COMPANY SNAPSHOT 175
    • 14.9.2 PRODUCT PORTFOLIO 175
    • 14.9.3 RECENT DEVELOPMENTS 175
  • 14.10 CEGAT GMBH 176
    • 14.10.1 COMPANY SNAPSHOT 176
    • 14.10.2 PRODUCT PORTFOLIO 176
    • 14.10.3 RECENT DEVELOPMENTS 176
  • 14.11 EUROFINS SCIENTIFIC 177
    • 14.11.1 COMPANY SNAPSHOT 177
    • 14.11.2 REVENUE ANALYSIS 177
    • 14.11.3 PRODUCT PORTFOLIO 178
    • 14.11.4 RECENT DEVELOPMENTS 178
  • 14.12 GENEDX, LLC 179
    • 14.12.1 COMPANY SNAPSHOT 179
    • 14.12.2 PRODUCT PORTFOLIO 179
    • 14.12.3 RECENT DEVELOPMENTS 179
  • 14.13 GENEFIRST LIMITED. 181
    • 14.13.1 COMPANY SNAPSHOT 181
    • 14.13.2 PRODUCT PORTFOLIO 181
    • 14.13.3 RECENT DEVELOPMENTS 181
  • 14.14 ILLUMINA, INC 183
    • 14.14.1 COMPANY SNAPSHOT 183
    • 14.14.2 REVENUE ANALYSIS 183
    • 14.14.3 PRODUCT PORTFOLIO 184
    • 14.14.4 RECENT DEVELOPMENTS 184
  • 14.15 INTEGRATED DNA TECHNOLOGIES, INC. 186
    • 14.15.1 COMPANY SNAPSHOT 186
    • 14.15.2 PRODUCT PORTFOLIO 186
    • 14.15.3 RECENT DEVELOPMENTS 186
  • 14.16 MERIDIAN BIOSCIENCE, INC. 188
    • 14.16.1 COMPANY SNAPSHOT 188
    • 14.16.2 REVENUE ANALYSIS 188
    • 14.16.3 PRODUCT PORTFOLIO 189
    • 14.16.4 RECENT DEVELOPMENTS 189
  • 14.17 PSOMAGEN 190
    • 14.17.1 COMPANY SNAPSHOT 190
    • 14.17.2 REVENUE ANALYSIS 190
    • 14.17.3 PRODUCT PORTFOLIO 190
    • 14.17.4 RECENT DEVELOPMENTS 191
  • 14.18 QIAGEN 192
    • 14.18.1 COMPANY SNAPSHOT 192
    • 14.18.2 REVENUE ANALYSIS 192
    • 14.18.3 PRODUCT PORTFOLIO 193
    • 14.18.4 RECENT DEVELOPMENTS 193
  • 14.19 SOPHIA GENETICS 194
    • 14.19.1 COMPANY SNAPSHOT 194
    • 14.19.2 REVENUE ANALYSIS 194
    • 14.19.3 PRODUCT PORTFOLIO 195
    • 14.19.4 RECENT DEVELOPMENTS 195
  • 14.20 TWIST BIOSCIENCE 196
    • 14.20.1 COMPANY SNAPSHOT 196
    • 14.20.2 REVENUE ANALYSIS 196
    • 14.20.3 PRODUCT PORTFOLIO 197
    • 14.20.4 RECENT DEVELOPMENTS 197

15 QUESTIONNAIRE 199

16 RELATED REPORTS 202

LIST OF TABLES

  • TABLE 1 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 61
  • TABLE 2 EUROPE SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 62
  • TABLE 3 EUROPE SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 63
  • TABLE 4 EUROPE THIRD-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 64
  • TABLE 5 EUROPE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 68
  • TABLE 6 EUROPE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 69
  • TABLE 7 EUROPE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 69
  • TABLE 8 EUROPE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 70
  • TABLE 9 EUROPE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 71
  • TABLE 10 EUROPE KITS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 72
  • TABLE 11 EUROPE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 72
  • TABLE 12 EUROPE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 73
  • TABLE 13 EUROPE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 74
  • TABLE 14 EUROPE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 78
  • TABLE 15 EUROPE DRUG DISCOVERY AND DEVELOPMENT IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 79
  • TABLE 16 EUROPE AGRICULTURE & ANIMAL RESEARCH IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 80
  • TABLE 17 EUROPE DIAGNOSTICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 81
  • TABLE 18 EUROPE PERSONALIZED MEDICINE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 82
  • TABLE 19 EUROPE OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 82
  • TABLE 20 EUROPE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 86
  • TABLE 21 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 87
  • TABLE 22 EUROPE ACADEMIC & RESEARCH INSTITUTES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 88
  • TABLE 23 EUROPE HOSPITALS AND CLINICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 24 EUROPE CLINICAL LABORATORIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 90
  • TABLE 25 EUROPE OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 90
  • TABLE 26 EUROPE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 94
  • TABLE 27 EUROPE DIRECT TRADE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 28 EUROPE RETAIL SALES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 96
  • TABLE 29 EUROPE OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 30 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 103
  • TABLE 31 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 103
  • TABLE 32 EUROPE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 103
  • TABLE 33 EUROPE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 34 EUROPE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 35 EUROPE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 36 EUROPE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 37 EUROPE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 38 EUROPE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 39 EUROPE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 105
  • TABLE 40 EUROPE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 106
  • TABLE 41 EUROPE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 106
  • TABLE 42 GERMANY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 107
  • TABLE 43 GERMANY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 107
  • TABLE 44 GERMANY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 107
  • TABLE 45 GERMANY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 108
  • TABLE 46 GERMANY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 108
  • TABLE 47 GERMANY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 108
  • TABLE 48 GERMANY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 108
  • TABLE 49 GERMANY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 50 GERMANY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 109
  • TABLE 51 GERMANY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 109
  • TABLE 52 GERMANY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 110
  • TABLE 53 FRANCE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 111
  • TABLE 54 FRANCE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 111
  • TABLE 55 FRANCE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 111
  • TABLE 56 FRANCE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 111
  • TABLE 57 FRANCE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 58 FRANCE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 59 FRANCE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 60 FRANCE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 61 FRANCE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 113
  • TABLE 62 FRANCE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 113
  • TABLE 63 FRANCE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 113
  • TABLE 64 U.K. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 114
  • TABLE 65 U.K. SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 114
  • TABLE 66 U.K. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 114
  • TABLE 67 U.K. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 68 U.K. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 69 U.K. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 70 U.K. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 71 U.K. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 116
  • TABLE 72 U.K. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 116
  • TABLE 73 U.K. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 116
  • TABLE 74 U.K. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 117
  • TABLE 75 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 118
  • TABLE 76 RUSSIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 118
  • TABLE 77 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 118
  • TABLE 78 RUSSIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 118
  • TABLE 79 RUSSIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 80 RUSSIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 81 RUSSIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 82 RUSSIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 83 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 120
  • TABLE 84 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 120
  • TABLE 85 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 120
  • TABLE 86 ITALY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 121
  • TABLE 87 ITALY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 121
  • TABLE 88 ITALY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 121
  • TABLE 89 ITALY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 121
  • TABLE 90 ITALY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 122
  • TABLE 91 ITALY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 122
  • TABLE 92 ITALY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 122
  • TABLE 93 ITALY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 122
  • TABLE 94 ITALY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 123
  • TABLE 95 ITALY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 123
  • TABLE 96 ITALY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 123
  • TABLE 97 SPAIN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 124
  • TABLE 98 SPAIN SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 124
  • TABLE 99 SPAIN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 124
  • TABLE 100 SPAIN SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 124
  • TABLE 101 SPAIN HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 125
  • TABLE 102 SPAIN ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 125
  • TABLE 103 SPAIN KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 125
  • TABLE 104 SPAIN SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 125
  • TABLE 105 SPAIN WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 126
  • TABLE 106 SPAIN WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 126
  • TABLE 107 SPAIN WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 126
  • TABLE 108 TURKEY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 127
  • TABLE 109 TURKEY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 127
  • TABLE 110 TURKEY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 127
  • TABLE 111 TURKEY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 127
  • TABLE 112 TURKEY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 128
  • TABLE 113 TURKEY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 128
  • TABLE 114 TURKEY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 128
  • TABLE 115 TURKEY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 128
  • TABLE 116 TURKEY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 129
  • TABLE 117 TURKEY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 129
  • TABLE 118 TURKEY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 129
  • TABLE 119 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 130
  • TABLE 120 NETHERLANDS SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 130
  • TABLE 121 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 130
  • TABLE 122 NETHERLANDS SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 131
  • TABLE 123 NETHERLANDS HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 131
  • TABLE 124 NETHERLANDS ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 131
  • TABLE 125 NETHERLANDS KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 131
  • TABLE 126 NETHERLANDS SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 132
  • TABLE 127 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 132
  • TABLE 128 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 132
  • TABLE 129 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 133
  • TABLE 130 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 134
  • TABLE 131 SWITZERLAND SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 134
  • TABLE 132 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 134
  • TABLE 133 SWITZERLAND SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 135
  • TABLE 134 SWITZERLAND HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 135
  • TABLE 135 SWITZERLAND ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 135
  • TABLE 136 SWITZERLAND KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 135
  • TABLE 137 SWITZERLAND SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 136
  • TABLE 138 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 136
  • TABLE 139 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 136
  • TABLE 140 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 137
  • TABLE 141 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 138
  • TABLE 142 BELGIUM SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 138
  • TABLE 143 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 138
  • TABLE 144 BELGIUM SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 139
  • TABLE 145 BELGIUM HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 139
  • TABLE 146 BELGIUM ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 139
  • TABLE 147 BELGIUM KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 139
  • TABLE 148 BELGIUM SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 140
  • TABLE 149 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 140
  • TABLE 150 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 140
  • TABLE 151 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 141
  • TABLE 152 REST OF EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 142

LIST OF FIGURES

  • FIGURE 1 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 25
  • FIGURE 2 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION 28
  • FIGURE 3 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS 29
  • FIGURE 4 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 30
  • FIGURE 5 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS 30
  • FIGURE 6 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS 31
  • FIGURE 7 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID 33
  • FIGURE 8 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID 35
  • FIGURE 9 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: VENDOR SHARE ANALYSIS 37
  • FIGURE 10 EUROPE WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 41
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE WHOLE EXOME SEQUENCING (WES) MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 42
  • FIGURE 12 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE EUROPE WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 43
  • FIGURE 13 THE INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WHOLE EXOME SEQUENCING (WES) MARKET IN 2022 & 2029 43
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE WHOLE EXOME SEQUENCING MARKET 51
  • FIGURE 15 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2021 58
  • FIGURE 16 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION) 59
  • FIGURE 17 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029) 59
  • FIGURE 18 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE 60
  • FIGURE 19 EUROPE WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2021 65
  • FIGURE 20 EUROPE WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022-2029 (USD MILLION) 66
  • FIGURE 21 EUROPE WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2022-2029) 66
  • FIGURE 22 EUROPE WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE 67
  • FIGURE 23 EUROPE WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2021 75
  • FIGURE 24 LOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 76
  • FIGURE 25 EUROPE WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2022-2029) 76
  • FIGURE 26 EUROPE WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE 77
  • FIGURE 27 EUROPE WHOLE EXOME SEQUENCING MARKET: BY END USER, 2021 83
  • FIGURE 28 EUROPE WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022-2029 (USD MILLION) 84
  • FIGURE 29 EUROPE WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2022-2029) 84
  • FIGURE 30 EUROPE WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE 85
  • FIGURE 31 EUROPE WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2021 91
  • FIGURE 32 EUROPE WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 92
  • FIGURE 33 EUROPE WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 92
  • FIGURE 34 EUROPE WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 93
  • FIGURE 35 EUROPE WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021) 99
  • FIGURE 36 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021) 100
  • FIGURE 37 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029) 100
  • FIGURE 38 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029) 101
  • FIGURE 39 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029) 101
  • FIGURE 40 EUROPE WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%) 142
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!